Evaluation of anticancer activities of novel facile synthesized calix[n]arene sulfonamide analogs
| dc.authorid | 0000-0002-6315-3018 | en_US |
| dc.authorid | 0000-0002-8049-7867 | en_US |
| dc.authorid | 0000-0002-0416-2870 | en_US |
| dc.contributor.author | Yılmaz, Bahar | |
| dc.contributor.author | Bayraç, Abdullah Tahir | |
| dc.contributor.author | Bayrakcı, Mevlüt | |
| dc.date.accessioned | 2019-12-26T08:31:55Z | |
| dc.date.available | 2019-12-26T08:31:55Z | |
| dc.date.issued | 2019 | en_US |
| dc.department | KMÜ, Mühendislik Fakültesi, Biyomühendislik Bölümü | en_US |
| dc.description | WOS:000499232500005 | en_US |
| dc.description.abstract | Here, new calixarene sulfonamide analogs were synthesized from the reaction of chlorosulfonated calix[n]arene (n: 4, 6, and 8) with N,N′-dimethylethylenediamine or ethylenediamine for the first time and an excellent calixarene sulfonamide analog showing potent and selective cytotoxic activity on some cancer cell lines were discovered. Cytotoxicity of the prepared calix[n]arene sulfonamide analogs towards both cancer and healthy cell lines was assessed by performing cell growth inhibition assays. In cytotoxicity assay results, it was observed that while sulfonamide analog based calix[4]arene (9) was not affecting the growth of epithelial cell lines (HEK), and it was especially effective on inhibiting the growth of some human cancer cell lines (MCF-7 and MIA PaCa-2). These results highlight that sulfonamide analog–based calix [4] arene (9) can be further studied as a potential anticancer agent. | en_US |
| dc.identifier.citation | Yilmaz, B., Bayrac, A. T., & Bayrakci, M. (November 28, 2019). Evaluation of Anticancer Activities of Novel Facile Synthesized Calix[n]arene Sulfonamide Analogs. Applied Biochemistry and Biotechnology. 1-14. | en_US |
| dc.identifier.doi | 10.1007/s12010-019-03184-x | |
| dc.identifier.issn | 0273-2289 | |
| dc.identifier.issn | 1559-0291 | |
| dc.identifier.pmid | 31782087 | |
| dc.identifier.scopus | 2-s2.0-85075856008 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.uri | https://doi.org/10.1007/s12010-019-03184-x | |
| dc.identifier.uri | https://hdl.handle.net/11492/3245 | |
| dc.identifier.wos | WOS:000499232500005 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Sceince | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.institutionauthor | Yılmaz, Bahar | |
| dc.institutionauthor | Bayraç, Abdullah Tahir | |
| dc.institutionauthor | Bayrakcı, Mevlüt | |
| dc.language.iso | en | |
| dc.publisher | Springer (part of Springer Nature) | en_US |
| dc.relation.journal | Applied Biochemistry and Biotechnology | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.relation.tubitak | 116Z979 | |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Calixarene | en_US |
| dc.subject | Sulfonamide | en_US |
| dc.subject | Anticancer | en_US |
| dc.subject | Breast Cancer | en_US |
| dc.subject | Pancreatic Cancer | en_US |
| dc.title | Evaluation of anticancer activities of novel facile synthesized calix[n]arene sulfonamide analogs | en_US |
| dc.type | Article |












